Purchase Order SPE2DP25P0609

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $37,832.55 firm fixed-price purchase order by the Department of Defense's Medical Supply Chain on August 10, 2025, with an ultimate completion date of August 25, 2025. The contract is designated as a Total Small Business set-aside and covers the supply of Meningococcal Group vaccines and related pharmaceutical products to support federal healthcare operations. The award leverages DMS Pharmaceutical Group's established position as a critical supplier within the Defense Logistics Agency's pharmaceutical supply network and complements the company's broader portfolio of medical product deliveries to military health facilities nationwide.

This purchase order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and effective through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting Department of Defense medical supply requirements. The award reflects the company's longstanding role in the federal pharmaceutical supply chain, where it has consistently delivered branded and generic prescription drugs, biologics, vaccines, and medical consumables to military healthcare facilities across the United States.